SOPHIRIS BIO INC.
DelistedCIK 1563855fmd_1ZCQ4VNBBK70F6830MDT825KVAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 11, 2002 to Sep 30, 2019, 41 periods
Latest annual · FY2018
Millions- Net income
- (7)
- Free cash flow
- (13)
Latest quarter · Q3 FY2019
Millions- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2013 to FY2018
- n/m
SOPHIRIS BIO INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Net income | -$6.8 million | -$8.6 million | 10-K 2019-03-13 · proof | |
| Cash from operating activities | -$13.5 million | -$10 million | 10-K 2019-03-13 · proof | |
| Free cash flow | -$13.5 million | -$10 million | 10-K 2019-03-13 · proof | |
| Total assets | $13.2 million | $26.9 million | -50.9% | 10-K 2019-03-13 · proof |
| Total liabilities | $11.5 million | $19.2 million | -40.4% | 10-K 2019-03-13 · proof |
| Cash and cash equivalents | $11 million | $16.1 million | -31.6% | 10-K 2019-03-13 · proof |
| Total debt | $7 million | $6.8 million | +3% | 10-K 2019-03-13 · proof |
- What was SOPHIRIS BIO INC.'s net income in fiscal 2018?
- SOPHIRIS BIO INC. reported net income of -$6.8 million for fiscal 2018 (the year ended Dec 31, 2018), against -$8.6 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What was SOPHIRIS BIO INC.'s cash from operating activities in fiscal 2018?
- SOPHIRIS BIO INC. reported cash from operating activities of -$13.5 million for fiscal 2018 (the year ended Dec 31, 2018), against -$10 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What was SOPHIRIS BIO INC.'s free cash flow in fiscal 2018?
- SOPHIRIS BIO INC. reported free cash flow of -$13.5 million for fiscal 2018 (the year ended Dec 31, 2018), against -$10 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What are SOPHIRIS BIO INC.'s total assets?
- As of Dec 31, 2018, SOPHIRIS BIO INC. reported total assets of $13.2 million, against $26.9 million a year earlier (-50.9%). Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What are SOPHIRIS BIO INC.'s total liabilities?
- As of Dec 31, 2018, SOPHIRIS BIO INC. reported total liabilities of $11.5 million, against $19.2 million a year earlier (-40.4%). Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What are SOPHIRIS BIO INC.'s cash and cash equivalents?
- As of Dec 31, 2018, SOPHIRIS BIO INC. reported cash and cash equivalents of $11 million, against $16.1 million a year earlier (-31.6%). Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
- What is SOPHIRIS BIO INC.'s total debt?
- As of Dec 31, 2018, SOPHIRIS BIO INC. reported total debt of $7 million, against $6.8 million a year earlier (+3%). Source: the 10-K filed with the SEC on Mar 13, 2019. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1563855&period_type=annual&limit=5"Information only, not investment advice.